The VA position on ibogaine
The Department of Veterans Affairs does not fund, facilitate, or refer veterans to ibogaine treatment. Here is why — and what advocacy efforts are underway to change that.
The Department of Veterans Affairs does not fund, facilitate, or refer veterans to ibogaine treatment. Ibogaine is Schedule I under federal law, and the VA operates within federal regulatory constraints.
What this means in practice
- VA clinicians cannot prescribe ibogaine or refer veterans to ibogaine providers.
- VA insurance does not cover ibogaine treatment, domestic or international.
- Travel to international treatment is not VA-funded.
- Post-treatment integration support is not formally available through the VA, though some VA mental-health providers are willing to support patients in integration of psychedelic experiences when patients self-disclose.
Active advocacy
The VA’s position has been a source of frustration for veteran advocates. Ongoing advocacy efforts have focused on:
- Community Care Act expansion to allow VA funding of qualified non-VA providers, including potentially international ibogaine clinics.
- Service-connected disability framing for treatment costs related to PTSD and TBI.
- Research participation pathways under NDAA Section 723.
None of these advocacy efforts have yet produced VA-funded access to ibogaine treatment. The April 2026 Trump administration executive order directing federal agencies to fast-track ibogaine review may begin to shift this; for now, the VA position remains unchanged.